Edwards Lifesciences (EW) Operating Expenses (2016 - 2026)
Edwards Lifesciences has reported Operating Expenses over the past 17 years, most recently at $766.9 million for Q4 2025.
- For Q4 2025, Operating Expenses rose 0.7% year-over-year to $766.9 million; the TTM value through Dec 2025 reached $3.1 billion, up 6.47%, while the annual FY2025 figure was $3.2 billion, 10.23% up from the prior year.
- Operating Expenses for Q4 2025 was $766.9 million at Edwards Lifesciences, down from $795.4 million in the prior quarter.
- Over five years, Operating Expenses peaked at $862.2 million in Q4 2023 and troughed at $336.6 million in Q4 2022.
- A 5-year average of $680.5 million and a median of $700.8 million in 2024 define the central range for Operating Expenses.
- Biggest five-year swings in Operating Expenses: crashed 49.3% in 2022 and later skyrocketed 156.15% in 2023.
- Year by year, Operating Expenses stood at $663.9 million in 2021, then crashed by 49.3% to $336.6 million in 2022, then skyrocketed by 156.15% to $862.2 million in 2023, then fell by 11.67% to $761.6 million in 2024, then grew by 0.7% to $766.9 million in 2025.
- Business Quant data shows Operating Expenses for EW at $766.9 million in Q4 2025, $795.4 million in Q3 2025, and $782.4 million in Q2 2025.